|
注册号: Registration number: |
ChiCTR2500104144 |
|
最近更新日期: Date of Last Refreshed on: |
2026-01-23 15:50:24 |
|
注册时间: Date of Registration: |
2025-06-11 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
基于复杂干预框架的产后期抑郁干预措施的开发和评估 |
|
Public title: |
Development and evaluation of a complex intervention framework-based intervention for postpartum depression |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
基于复杂干预框架的产后期抑郁干预措施的开发和评估 |
|
Scientific title: |
Development and evaluation of a complex intervention framework-based intervention for postpartum depression |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
柏艳萍 |
研究负责人: |
柏艳萍; 龚雯洁 |
|
Applicant: |
Bai Yanping |
Study leader: |
Bai Yanping ; Gong Wenjie |
|
申请注册联系人电话: Applicant telephone: |
+86 188 3899 0761 |
研究负责人电话:
Study leader's |
+86 136 0744 5252 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
ypingbai@163.com |
研究负责人电子邮件: Study leader's E-mail: |
gongwenjie@csu.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
湖南省长沙市岳麓区桐梓坡路 172号 |
研究负责人通讯地址: |
湖南省长沙市岳麓区桐梓坡路 172号 |
|
Applicant address: |
172 Tongzipo Road, Yuelu District, Changsha, Hunan, China |
Study leader's address: |
172 Tongzipo Road, Yuelu District, Changsha, Hunan, China |
|
申请注册联系人邮政编码: Applicant postcode: |
410013 |
研究负责人邮政编码: Study leader's postcode: |
410013 |
|
申请人所在单位: |
中南大学湘雅公共卫生学院 |
||
|
Applicant's institution: |
Central South University |
||
|
研究负责人所在单位: |
中南大学湘雅公共卫生学院 |
||
|
Affiliation of the Leader: |
Central South University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
XYGW-2025-75号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
中南大学湘雅公共卫生学院 |
||
|
Name of the ethic committee: |
Xiangya School of Public Health Central South University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-06-05 00:00:00 | ||
|
伦理委员会联系人: |
关岚 |
||
|
Contact Name of the ethic committee: |
Guan Lan |
||
|
伦理委员会联系地址: |
湖南省长沙市岳麓区桐梓坡路 172号 |
||
|
Contact Address of the ethic committee: |
172 Tongzipo Road, Yuelu District, Changsha, Hunan, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 731 8480 5414 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
中南大学湘雅公共卫生学院 |
||||||||||||||||||||||
|
Primary sponsor: |
Xiangya School of Public Health Central South University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
湖南省长沙市岳麓区桐梓坡路 172号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
172 Tongzipo Road, Yuelu District, Changsha, Hunan, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
国家自然科学基金 |
||||||||||||||||||||||
|
Source(s) of funding: |
National Natural Science Foundation of China |
||||||||||||||||||||||
|
研究疾病: |
产后抑郁 |
||||||||||||||||||||||
|
Target disease: |
Postpartum depression |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
析因分组(即根据危险因素或暴露因素分组) |
||||||||||||||||||||||
|
Study design: |
Factorial |
||||||||||||||||||||||
|
研究目的: |
本研究采用多阶段优化策略(MOST)框架,通过混合方法研究和析因整群随机对照试验,系统评估基于基层妇幼保健网络的PPD干预方案。 |
||||||||||||||||||||||
|
Objectives of Study: |
This study used a multiphase optimization strategy (MOST) framework, employing mixed-methods research and factorial cluster randomized controlled trials to systematically evaluate PPD intervention programs based on primary Maternal and Child Health-care ( MCH) networks. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1. 不能独立完成问卷填写; 2. 存在其他急慢性疾病导致无法参与研究。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Inability to complete the questionnaire independently; 2. Presence of other acute and chronic diseases that prevented participation in the study. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-05-01 00:00:00至 To 2026-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2025-07-09 00:00:00 至 To 2026-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
女性 |
Gender: |
Female |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
利用计算机随机数字法将各街道/乡镇随机分配至8种干预组合条件(表1),以系统评估各干预组分的独立效应及交互作用。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
This trial will randomize neighborhoods/townships to all 8 intervention combinations using computer-generated random numbers to allocate each neighborhood/township to one of eight possible intervention combinations (Table 1), enabling systematic evaluation of both independent and interaction effects among intervention components. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
为最大限度控制偏倚,研究实施三重盲法设计:(a)数据管理团队不接触随机化序列;(b)统计分析人员保持盲态至分析完成;(c)结局评估者不知晓分组信息。鉴于干预措施的特性,参与者无法实现完全盲法,可能引入报告偏倚。 |
|
Blinding: |
A triple-blind design was implemented in the study: (a) the data management team did not have access to the randomization sequence; (b) the statistical analysts remained blinded until the analysis was completed; (c) the outcome assessors were unaware of the group assignments. Given the nature of the intervention, participants could not be completely blinded, which may have introduced reporting bias. |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
不共享原始数据 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
No sharing of original data |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
定性资料使用录音笔采集和管理;定量资料使用问卷星和Redcap采集和管理。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Qualitative information was collected and managed using audio recorders; quantitative information was collected and managed using Wenjuanxing and Redcap. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |